<qa>  What is the name of the PLACEBO-CONTROLLED DULOXETRANDOMISED PLACEBO-CONTROLLED DULOXETINE-REFERENCED EFFICACY AND SAFETY STUDY OF 2.5, 5 AND 10 MG OF VORTIOXETINE LU AA21004 IN ACUTE TREATMENT OF MAJOR DEPRESSIVE DISORDER: 